Study Design of the Diacerein in Patients With Covid-19

NCT05226754 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Diacerein
DRUG: placebo capsules

Sponsor

University of Campinas, Brazil

Collaborators

[object Object]